Literature DB >> 2333482

Diagnosis of alcohol use disorders in schizophrenia.

R E Drake1, F C Osher, D L Noordsy, S C Hurlbut, G B Teague, M S Beaudett.   

Abstract

Alcohol use disorders are common comorbid conditions in schizophrenia, and their presence is associated with poor adjustment and poor treatment response. Standard alcohol assessment instruments have not been validated for use with schizophrenic patients, and several authors have questioned the validity of these patients' self-reports. A reliable and valid screening procedure for assessing alcohol use is needed. The present study used the following three methods to evaluate a rural sample of 75 outpatients with DSM-III-R schizophrenia or schizoaffective disorder: (1) clinical records; (2) research interviews using standard alcohol assessment instruments; and (3) case managers' ratings. In addition, consensus diagnoses, determined by combining information from all three methods with intensive case reviews, were used to determine the sensitivity and specificity of the other approaches. As expected, clinical evaluations frequently missed alcohol problems. Research interviews and case managers' ratings differentiated between alcoholic and nonalcoholic schizophrenic patients and were highly correlated. Case managers' ratings, which incorporated longitudinal observations of behavior and collateral reports as well as interview data, were more sensitive measures of current alcohol use disorders than research interviews. Subjects frequently manifested alcohol-related problems that interfered with community adjustment without the full dependence syndrome, suggesting that schizophrenic patients may be particularly vulnerable to negative effects of alcohol.

Entities:  

Mesh:

Year:  1990        PMID: 2333482     DOI: 10.1093/schbul/16.1.57

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  87 in total

1.  Assessing readiness for change among persons with severe mental illness.

Authors:  E S Rogers; R Martin; W Anthony; J Massaro; K Danley; T Crean; W Penk
Journal:  Community Ment Health J       Date:  2001-04

Review 2.  Cannabis and psychosis.

Authors:  Louisa Degenhardt; Wayne Hall
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

3.  Long-term sobriety strategies for men with co-occurring disorders.

Authors:  Alison Luciano; Elisabeth L Bryan; Elizabeth A Carpenter-Song; Mary Woods; Katherine Armstrong; Robert E Drake
Journal:  J Dual Diagn       Date:  2014

4.  Perceived reasons for substance misuse among persons with a psychiatric disorder.

Authors:  Alexandra B Laudet; Stephen Magura; Howard S Vogel; Edward L Knight
Journal:  Am J Orthopsychiatry       Date:  2004-07

5.  A comparison of adolescent- and adult-onset first-episode, non-affective psychosis: 2-year follow-up.

Authors:  Johannes Langeveld; Inge Joa; Svein Friis; Wenche ten Velden Hegelstad; Ingrid Melle; Jan O Johannessen; Stein Opjordsmoen; Erik Simonsen; Per Vaglum; Bjørn Auestad; Thomas McGlashan; Tor K Larsen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-03-23       Impact factor: 5.270

6.  Criminal justice involvement of individuals with severe mental illness and supported employment outcomes.

Authors:  Rochelle Frounfelker; Alexandra Teachout; Gary R Bond; Robert E Drake
Journal:  Community Ment Health J       Date:  2010-08-03

7.  Recovery from serious mental illness: trajectories, characteristics, and the role of mental health care.

Authors:  Carla A Green; Nancy A Perrin; Michael C Leo; Shannon L Janoff; Bobbi Jo H Yarborough; Robert I Paulson
Journal:  Psychiatr Serv       Date:  2013-12-01       Impact factor: 3.084

8.  Impact of interpersonal trauma on the social functioning of adults with first-episode psychosis.

Authors:  Helen J Stain; Kolbjørn Brønnick; Wenche T V Hegelstad; Inge Joa; Jan O Johannessen; Johannes Langeveld; Lauren Mawn; Tor K Larsen
Journal:  Schizophr Bull       Date:  2013-11-26       Impact factor: 9.306

9.  Time to discontinuation of antipsychotic drugs in a schizophrenia cohort: influence of current treatment strategies.

Authors:  Rune A Kroken; Eirik Kjelby; Tore Wentzel-Larsen; Liv S Mellesdal; Hugo A Jørgensen; Erik Johnsen
Journal:  Ther Adv Psychopharmacol       Date:  2014-12

10.  Examination of heterogeneity in treatment response to antipsychotic medications.

Authors:  Natalie Bareis; T Scott Stroup
Journal:  Schizophr Res       Date:  2019-08-01       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.